跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Max-3
首页
药物
Max-3
Max-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
US 7262295 B2
申请人: TRANSITIONS OPTICAL INC
优先权: 2003
CN
EP
US
WO
8 件公开
METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESSION OF TRANSCRIPTION FACTORS
EP 4419679 A1
申请人: UNIV ROCHESTER
优先权: 2021
EP
US
7 件公开
INORGANIC EFFECT PIGMENTS
EP 3607004 B1
申请人: SUN CHEMICAL BV
优先权: 2017
CN
EP
US
3 件公开
Drinkable immediate release tablet made with direct compression of memantine or neramexane
EP 2601937 A1
申请人: MERZ PHARMA GMBH & CO KGAA
优先权: 2004
CN
EP
2 件公开
FUNCTIONAL NATIVE POTATO PROTEIN, AND METHOD FOR PRODUCING SAME
US 20260103493 A1
申请人: EMSLAND STAERKE GMBH
优先权: 2022
EP
US
2 件公开
USE OF SOYBEAN MYC2-LIKE TRANSCRIPTION FACTOR GENE GMMYC3 AND KASP MARKER THEREOF
WO 2025107833 A1
申请人: UNIV NANJING AGRICULTURAL
优先权: 2023
CN
WO
2 件公开
Black soybean polysaccharides
US 2005107452 A1
申请人: WANG SHENG-YUAN
优先权: 2002
US
2 件公开
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
US 2006002999 A1
申请人: FOREST LABORATORIES
优先权: 2005
US
2 件公开
Process for making a colored make-up cosmetic composition with controlled transmittance
US 7023552 B2
申请人: OREAL
优先权: 2000
US
Spray pack
US 7094448 B2
申请人: ASAHI KASEI CHEMICAL CORP
优先权: 2002
US
第 1 / 4 页
上一页
下一页
药物
反馈